De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling-Reference-Cited by-同舟云学术

De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling

Published:2023-08-27 Issue:6 Volume:36 Page:2099-2112
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Uematsu Hiroyuki,Saito Chieko,Kondo Jumpei,Onuma Kunishige,Coppo Roberto,Mori Yukiko,Muto Manabu,Kikawa Yuichiro,Tada Manami,Sugie Tomoharu,Inoue Masahiro^ORCID

Funder

Kyoto University Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

https://link.springer.com/content/pdf/10.1007/s13577-023-00975-7.pdf

Reference31 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

2. Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol. 1984;2(10):1102–9.

3. Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med. 2011;62:233–47.

4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341–1352.

5. Aitken SJ, Thomas JS, Langdon SP, Harrison DJ, Faratian D. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol. 2010;21(6):1254–61.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts;Scientific Reports;2024-06-19

2. Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients;International Journal of Cancer;2024-03-27

3. Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells;2023-09-28